Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells

Autoria(s): Van Schaeybroeck, Sandra; Kyula, Joan; Kelly, D.; Karaiskou-McCaul, A.; Stokesberry, Susan; Van Cutsem, E.; Longley, Daniel; Johnston, Patrick
Data(s)

01/05/2006
Identificador

http://pure.qub.ac.uk/portal/en/publications/chemotherapyinduced-epidermal-growth-factor-receptor-activation-determines-response-to-combined-gefitinibchemotherapy-treatment-in-nonsmall-cell-lung-cancer-cells(34b354fc-3236-4238-a395-b502a1f9755e).html

http://dx.doi.org/10.1158/1535-7163.MCT-05-0446

http://www.scopus.com/inward/record.url?scp=33745059265&partnerID=8YFLogxK
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Van Schaeybroeck , S , Kyula , J , Kelly , D , Karaiskou-McCaul , A , Stokesberry , S , Van Cutsem , E , Longley , D & Johnston , P 2006 , ' Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells ' Molecular Cancer Therapeutics , vol 5(5) , no. 5 , pp. 1154-1165 . DOI: 10.1158/1535-7163.MCT-05-0446
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2730 #Oncology #/dk/atira/pure/subjectarea/asjc/3000/3002 #Drug Discovery #/dk/atira/pure/subjectarea/asjc/3000/3004 #Pharmacology
Tipo

article
Acesso ao item digital